Hemolytic uremic syndrome (HUS) primarily affects kidney function, causing damage through thrombotic microangiopathy and leading to variable long-term health outcomes, especially in children. Diagnosis involves monitoring glomerular filtration rate (GFR), serum creatinine levels, and urine analysis, with acute symptoms often including high blood pressure and proteinuria. Future kidney damage can manifest years later, necessitating long-term follow-up with medical professionals.